Arrowhead Pharmaceuticals... (ARWR)
Arrowhead Pharmaceuticals Max Pain By Strike
ARWR trades at $20.5, 28.1% above the near-term max pain of $16 expiring Sep 19, 2025 (34 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is rising across expirations ($14-$19), reflecting growing call interest at higher strikes. Key magnetic zone at 16 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Arrowhead Pharmaceuticals Max Pain By Expiry
Max pain for ARWR shows an upward trend from 14 to 19, suggesting bullish positioning in longer-dated options. The 31% spread signals divergent expectations across timeframes. Most levels below 20.5 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Sep 19, 2025 | 16 | -4.50 (-21.97%) |
| Oct 17, 2025 | 19 | -1.50 (-7.34%) |
| Dec 19, 2025 | 16 | -4.50 (-21.97%) |
| Mar 20, 2026 | 14 | -6.50 (-31.72%) |